Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia
2009
Hydrogen sulfide mediates the vasoactivity of garlic
2007 Standout
Atrial Fibrillation and Death After Myocardial Infarction
2011
Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure
2012
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Survivors of out-of-hospital cardiac arrest with apparently normal heart: Need for definition and standardized clinical evaluation
1997
Structure of a mammalian ryanodine receptor
2014 StandoutNatureNobel
Ventricular arrhythmogenesis: Insights from murine models
2008
Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures
1995
Ryanodine receptors and ventricular arrhythmias: Emerging trends in mutations, mechanisms and therapies
2006
Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation
1989
The Brugada Syndrome: Is an Implantable Cardioverter Defibrillator the Only Therapeutic Option?
2002
Universal Definition of Myocardial Infarction
2007 Standout
Coronary artery apoptosis in experimental hypercholesterolemia
1999
The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction
1988
Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates
1990
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Risk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis
2006
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Ryanodine Receptors: Allosteric Ion Channel Giants
2014
J-Point Elevation in Survivors of Primary Ventricular Fibrillation and Matched Control Subjects
2008
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Mode of onset of torsade de pointes in congenital long QT syndrome
1996
Hydrogels in Regenerative Medicine
2009 Standout
Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials
2012
Prospects for Cardiovascular Research
2001 StandoutNobel
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Hereditary dilated cardiomyopathy
1995
Genome-wide Orchestration of Cardiac Functions by the Orphan Nuclear Receptors ERRα and γ
2007
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
2009
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Cushing's syndrome
2015 Standout
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
Quinidine Induced Electrocardiographic Normalization in Two Patients with Brugada Syndrome
2001
Hydroquinidine therapy in Brugada syndrome
2004
Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia
1996 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Genetic control of sodium channel function
2003
Ventricular Arrhythmias in the Absence of Structural Heart Disease
2012
Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry)
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
2002 StandoutNobel
Infants with long-QT syndrome and 2:1 atrioventricular block
1995
Electrophysiologic investigation in Brugada syndrome. Yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats
2002
The Brugada Syndrome: Ionic Basis and Arrhythmia Mechanisms
2001
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Effect of garlic on cardiovascular disorders: a review
2002 Standout
Use of Implantable Cardioverter-Defibrillators in the Congenital Long QT Syndrome
1996
Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure
2003
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia
2013
The long QT syndrome
1997
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
1995
Coronary Artery Stents
2000
Electrophysiologic characteristics andimplications of induced ventricular fibrillationin symptomatic patients with brugada syndrome
2002
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia
2006
Use of the Electrocardiogram in Acute Myocardial Infarction
2003
Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapy
1992
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Myocarditis
2011 Standout
Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia
2001
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Treatment of cardiac arrhythmias during pregnancy
1993
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel
1995 Standout
Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias
2000
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Implantable Cardioverter Defibrillator Therapy in Children with Long QT Syndrome
2004
Sudden Death Due to Cardiac Arrhythmias
2001
Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts
2010
Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: A case series and literature review
2012
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
2013
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes
2004
Clinical spectrum of patients with a Brugada ECG
2008
The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction
1999
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?
1989
Clinical experience with pacemaker pulse generators and transvenous leads: An 8-year prospective multicenter study
2006
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
2005
Secondary Prevention of Sudden Death
2000
Role of sodium and calcium channel block in unmasking the Brugada syndrome
2004
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
1995 Standout
Genetic causes of human heart failure
2005
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
2008
Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice
2003
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases
2014
Myocarditis
2009 Standout
Survival after implantation of the cardioverter defibrillator
1992
Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia
1999
Antiplatelet therapy: in search of the 'magic bullet'
2003
Brugada Syndrome
2002
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Molecular Genetics of Arrhythmias and Cardiovascular Conditions Associated with Arrhythmias
2003
Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia
2012
Modulation of the Ryanodine Receptor and Intracellular Calcium
2007
Aortic Atherosclerotic Disease and Stroke
2006
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Laser angioplasty: Unraveling the gordian knot
1986
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome
2000
The Brugada Syndrome
1998
Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin
2004
Mapping and Ablation of Idiopathic Ventricular Fibrillation
2002
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Biomaterials in cardiac tissue engineering: Ten years of research survey
2008
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
2002
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options.
2005
The long QT syndrome in children. An international study of 287 patients.
1993
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration
2010 StandoutNobel
Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro.
1985
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)
2000 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation
1999
Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction
2011
Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy
2013
PHTHALOCYANINES AS PHOTODYNAMIC SENSITIZERS*
1991
Sudden Cardiac Death
1998 Standout
Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome.
1991
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Influence of body and arm position on blood pressure readings
2003
Cardiac abnormalities in familial palmoplantar keratosis.
1986
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
1993
Role of Transvenous Implantable Cardioverter-Defibrillators in Preventing Sudden Cardiac Death in Children, Adolescents, and Young Adults
2002
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Ischemic Mitral Regurgitation on the Threshold of a Solution
2005
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Catecholaminergic Polymorphic Ventricular Tachycardia in Children
1995
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Acute Myocardial Infarction Complicated by Atrial Fibrillation in the Elderly
2000
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia
2002
PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern
2012
Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials
2015
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Molecular Basis of Arrhythmias
2005
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Effects of single- and biventricular pacing on temporal and spatial dynamics of ventricular contraction
2002
Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias.
1994
Multiple Mechanisms in the Long-QT Syndrome
1996
Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty
1987 Standout
Gene for Arrhythmogenic Right Ventricular Cardiomyopathy With Diffuse Nonepidermolytic Palmoplantar Keratoderma and Woolly Hair (Naxos Disease) Maps to 17q21
1998
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia
2003
Works of Michael Eldar being referenced
Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits
1990
A missense mutation in CASQ2 is associated with autosomal recessive catecholamine‐induced polymorphic ventricular tachycardia in Bedouin families from Israel
2004
Exercise-induced doub;e (atrial and ventricular) tachycardia: A report of three cases
1989
Serum basic fibroblast growth factor levels in patients with ischemic heart disease
1997
Results of percutaneous transluminal angioplasty of the left main coronary artery
1991
Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome
1999
Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome
1992
Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging
2002
Mechanism of mitral regurgitation in inferior wall acute myocardial infarction
2002
A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel
2001
Reverse Remodeling and the Risk of Ventricular Tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy)
2011
Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT
2010
Long-term prognostic significance of left atrial volume in acute myocardial infarction
2004
Mode of Onset of Malignant Ventricular Arrhythmias in Idiopathic Ventricular Fibrillation
1997
Deformation Dynamics and Mechanical Properties of the Aortic Annulus by 4-Dimensional Computed Tomography
2012
Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium
1993
Cytotoxic T Lymphocytes Are Activated Following Myocardial Infarction and Can Recognize and Kill Healthy Myocytes In Vitro
2000
Impact of the Metabolic Syndrome on the Clinical Outcomes of Non-Clinically Diagnosed Diabetic Patients With Acute Coronary Syndrome
2007
Sudden cardiac death and polymorphous ventricular tachycardia in pationts with normal QT intervals and normal systolic cardiac function
1995
ST‐Segment Deviation Following Implantable Cardioverter Defibrillator Shocks: Incidence, Timing, and Clinical Significance
2002
Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era
1999
Long‐Term Performance of Screw‐In Atrial Pacing Leads: A Randomized Comparison of J‐Shaped and Straight Leads
2005
Long-Term Follow-Up of Patients With Long-QT Syndrome Treated With β-Blockers and Continuous Pacing
1999
Changes in Blood Pressure in the Lying and Sitting Positions in Normotensive, Borderline and Hypertensive Subjects
1983
Arrhythmogenic right ventricular dysplasia in a family
1985
Transcutaneous Multielectrode Basket Catheter for Endocardial Mapping and Ablation of Ventricular Tachycardia in the Pig
1997
Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet
1999
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
2011
Permanent cardiac pacing in patients with the long QT syndrome
1987
Medical treatment of cardiovascular disorders during pregnancy
1982
Significance of Paroxysmal Atrial Fibrillation Complicating Acute Myocardial Infarction in the Thrombolytic Era
1998
Catecholaminergic Polymorphic Ventricular Tachycardia from Bedside to Bench and Beyond
2008
Electrophysiologic testing and follow-up of patients with aborted sudden death
1987
Recombinant von Willebrand Factor Fragment AR545C Inhibits Platelet Aggregation and Enhances Thrombolysis With rtPA in a Rabbit Thrombosis Model
1998
Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia
2001
Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia
2007
Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients.
2007
Transluminal carbon dioxide-laser catheter angioplasty for dissolution of atherosclerotic plaques
1984